Award
National Cancer Institute 5R01CA272490-04
Mitochondrial NAD+ in Acute Myeloid Leukemias
Recipient
University of Texas at Austin
Award Amount
$522,539.00
Ceiling
$522,539.00
Awarded
August 03, 2026
Identifier
5R01CA272490-04
Award for research on mitochondrial NAD+ in Acute Myeloid Leukemias aimed at developing targeted therapies, administered by the National Cancer Institute.
Description
The project focuses on investigating mitochondrial NAD+ in Acute Myeloid Leukemias, with a long-term goal of developing targeted therapies. The award is administered by the National Cancer Institute (NCI), part of the NIH. The project involves extensive research on mitochondrial metabolism, genetic regulation, and potential therapeutic targets.